Stocks

The table gives an overview of all stocks, alphabetically sorted.
 S.D. Standard Drilling SDSDO Mar 3, 2021 1.15 -4.96   
 S2Medical S2M Mar 3, 2021 7.99 +0.76   
 SAAB B SAABB Mar 3, 2021 225.00 -0.31   
 Safe at Sea SAFE Mar 3, 2021 1.88 +3.87   
 Safe Lane Gaming B SLGB Mar 3, 2021 0.28 0.00   
 Safeture SFTR Mar 3, 2021 9.36 -1.27   
 Saga Pure SAGAO Mar 3, 2021 3.00 0.00   
 Sagax A SAGAA Mar 3, 2021 187.00 +0.54   
 Sagax B SAGAB Mar 3, 2021 186.80 +1.52   
 Sagax D SAGAD Mar 3, 2021 31.80 +0.63   
 Sagax Pref SAGAPREF Mar 3, 2021 35.30 +0.28   
 SalMar SALMO Mar 3, 2021 586.80 +1.07   
 Salmones Camanchaca SACAMO Mar 3, 2021 55.40 0.00   
 SaltX Technology Holding B SALTB Mar 3, 2021 5.56 -6.08   
 Samtrygg Group B SAMTB Mar 3, 2021 3.66 +4.57   
 Sandvik SAND Mar 3, 2021 231.30 -0.26   
 Saniona SANION Mar 3, 2021 19.44 +9.46   
 SARSYS-ASFT SARS Mar 3, 2021 3.70 +1.37   
 SAS SASNOO Mar 3, 2021 1.87 0.00   
 SAS SAS Mar 3, 2021 1.97 +5.56   
 SATS SATSO Mar 3, 2021 22.85 0.00   
 Savosolar SAVOS Mar 3, 2021 1.36 -1.74   
 Saxlund Group SAXG Mar 3, 2021 0.43 -0.92   
 Sbanken SBANKO Mar 3, 2021 79.85 0.00   
 SBB Norden B SBBB Mar 3, 2021 26.14 -1.36   
 SBB Norden D SBBD Mar 3, 2021 29.60 -1.00   
 SBB Norden Pref SBBPREF Mar 3, 2021 685.00 0.00   
 SCA A SCAA Mar 3, 2021 153.60 +0.92   
 SCA B SCAB Mar 3, 2021 151.10 +1.68   
 Scana SCANAO Mar 3, 2021 2.38 0.00   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK